141 related articles for article (PubMed ID: 7107390)
1. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
Spooner D; Peacock JH; Stephens TC
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):643-6. PubMed ID: 7107390
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitization of mouse tumors by misonidazole.
Randhawa VS; Stewart FA; Denekamp J
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):671-4. PubMed ID: 7107397
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
Stephens TC; Courtenay VD; Mills J; Peacock JH; Rose CM; Spooner D
Br J Cancer; 1981 Apr; 43(4):451-7. PubMed ID: 7236488
[TBL] [Abstract][Full Text] [Related]
4. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
5. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Clutterbuck RD; Millar JL; McElwain TJ
Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
Hirst DG; Brown JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
Roizin-Towle LA; Hall EJ
Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
Hirst DG; Brown JM; Hazlehurst JL
Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
[TBL] [Abstract][Full Text] [Related]
9. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
Hinchliffe M; McNally NJ; Stratford MR
Br J Cancer; 1983 Sep; 48(3):375-83. PubMed ID: 6615699
[TBL] [Abstract][Full Text] [Related]
10. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
Twentyman PR; Workman P
Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
[TBL] [Abstract][Full Text] [Related]
11. Azomycin riboside: a new radiosensitizer.
Pedersen JE; Barron G; Chapman JD
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
[TBL] [Abstract][Full Text] [Related]
12. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
13. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
[TBL] [Abstract][Full Text] [Related]
15. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
Wallen CA; Moore SK; Wheeler KT
Int J Radiat Oncol Biol Phys; 1992; 22(4):727-30. PubMed ID: 1531976
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Horsman MR; Evans JW; Brown JM
Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
[TBL] [Abstract][Full Text] [Related]
17. The in vitro sensitivities to radiation and misonidazole of mouse bone marrow cells derived from different microenvironments.
Allalunis-Turner J; Chapman JD
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Mar; 49(3):415-22. PubMed ID: 3485590
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cytotoxicity of 5-thio-D-glucose and misonidazole on hypoxic cells in vitro.
Song CW; Lee CK; Rhee JG; Levitt SH
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):749-52. PubMed ID: 6809705
[TBL] [Abstract][Full Text] [Related]
19. Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
Smith E; Stratford IJ; Adams GE
Br J Cancer; 1982 Jul; 46(1):117-26. PubMed ID: 7104191
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
Mulcahy RT; Dembs NL; Ublacker GA
Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
